HER2 Horizons National Meeting

Name: HER2 Horizons National Meeting
Start: 2024-10-18T10:00:00
End: 2024-10-18T16:30:00
Location: The Royal College of Surgeons

18 Oct 2024

About the event

The HER2 Horizons National Meeting is a promotional and educational event hosted and funded by AstraZeneca and Daiichi Sankyo; held in London on 27th April 2024. The event consists of a series of plenary presentations and interactive workshops designed to educate healthcare professionals treating metastatic breast cancer (mBC) living in the UK. The event is F2F only and will be led by a panel of mBC expert physicians including Dr Judy King; Dr Mark Verrill; Dr Duncan Wheatley; Professor Peter Schmid and Professor David Miles.

CPD Provider

AstraZeneca

View member

Send an enquiry

Full Name*

Email Address*

Contact Number*

Industry*

Your Enquiry*

By submitting this form, you consent to CPD sending you email regarding your application.

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Thank you for your enquiry. Your message will be sent to the relevant CPD provider to contact you directly. We hope this helps.

Are you using the My CPD Portal? Log in here.

Calquence National Summit

AstraZeneca

London,

19 Oct 2024

View Event

Healthcare & Medical

Calquence National Summit

AstraZeneca

London,

18 Oct 2024

View Event

Event Details

HER2 Horizons National Meeting

18 Oct 2024

10:00 - 16:30

The Royal College of Surgeons , The View, Lincoln’s Inn Fields, Holborn. WC2A 3PE

Get Directions

AstraZeneca

AstraZeneca is a global, science-led biopharmaceutical company that focuses on the discovery, development and commercialisation of prescription medicines. Our Purpose is to push the boundaries of science to deliver life-changing medicines. We believe the best way we can achieve our Purpose is to put science at the centre of everything we do. Science defines who we are. It is why we come to work every day and is part of our DNA. But this is only half of the story. We know that we do not have all the answers. We want to share ideas because we believe it results in better medicines. We want the way we work to be inclusive, open and collaborative. This approach runs through all that we do.